Loerrach, Germany

Georg Trickes

This inventor holds 1 USPTO granted patent. Top assignee: Basilea Pharmaceutica Ag. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Georg Trickes. Retrieved from https://idiyas.com/inventor/georg-trickes-vwhaw7ui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Georg Trickes: Innovator in Cephalosporin Derivatives

Introduction

Georg Trickes is a notable inventor based in Loerrach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin derivatives. His work has implications for antibiotic treatments, showcasing the importance of innovation in healthcare.

Latest Patents

Georg Trickes holds a patent for a "Process for producing cephalosporin derivatives." This patent highlights his expertise in pharmaceutical chemistry and his commitment to advancing medical science. The patent is a testament to his innovative approach and dedication to improving drug formulations.

Career Highlights

Trickes is currently employed at Basilea Pharmaceutica AG, a company known for its focus on developing innovative medicines. His role at Basilea allows him to work on cutting-edge research and contribute to the company's mission of addressing unmet medical needs. His career reflects a strong commitment to scientific advancement and patient care.

Collaborations

Georg Trickes collaborates with Paul Spurr, a fellow professional in the pharmaceutical industry. Their partnership exemplifies the collaborative spirit often found in research and development, where shared expertise can lead to groundbreaking discoveries.

Conclusion

Georg Trickes is a distinguished inventor whose work in cephalosporin derivatives has made a significant impact in the pharmaceutical field. His contributions, along with his collaboration with peers, continue to drive innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…